The Corticosteroid Receptor Hypothesis of Depression (original) (raw)
Alléra A, Wildt L . (1992): Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane. Kinetics of corticosterone uptake by isolated membrane vesicles. I. Binding and transport. J Steroid Biochem Mol Biol42: 737–756 PubMed Google Scholar
Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, Meyer M, Holsboer F, Michaelidis TM . (2000): Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J14: 779–790 CASPubMed Google Scholar
Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M . (1995): Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of lκB synthesis. Science270: 286–290 CASPubMed Google Scholar
Bale TI, Gontarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee K-F . (2000): Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genet24: 410–414 CASPubMed Google Scholar
Bamberger CM, Bamberger AM, DeCastro M, Chrousos GP . (1995): Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest95: 2435–2441 CASPubMedPubMed Central Google Scholar
Barden N, Stec I, Montkowski A, Holsboer F, Reul JMHM . (1997): Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology66: 212–220 CASPubMed Google Scholar
Beato M, Herrlich P, Schütz G . (1995): Steroid hormone receptors: Many actors in search of a plot. Cell83: 851–857 ArticleCASPubMed Google Scholar
Behan DJP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB . (1995): Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature378: 284–287 CASPubMed Google Scholar
Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F . (1997): Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology138: 101–106 CASPubMed Google Scholar
Berger S, Bleich M, Schmid W, Cole TJ, Peters J, Watanabe HWK, Warth R, Greger R, Schütz G . (1998): Mineralocorticoid receptor knockout mice: Pathophysiology of sodium metabolism. Proc Natl Acad Sci USA95: 9424–9429 CASPubMedPubMed Central Google Scholar
Bleuler M . (1919): The Internal Secretions and the Nervous System. (Nervous and Mental Disease Monograph Series, No. 30.) New York, Nervous and Mental Disease Publ Comp
Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M . (1991): Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest87: 831–837 CASPubMedPubMed Central Google Scholar
Bremner J, Southwick S, Charney D . (1999): The neurobiology of post-traumatic stress disorder: An integration of animal and human research. In Saigh P, Bremner J (eds), Post-traumatic Stress Disorder: A Comprehensive Text. Needham Heights, MA, Allyn & Cacon, pp 103–143 Google Scholar
Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS . (2000): Hippocampal volume reduction in major depression. Am J Psychiatry157: 115–117 CASPubMed Google Scholar
Burrows HL, Nakajima M, Lesh JS, Goosens KA, Samuelson LC, Inui A, Camper SA, Seasholtz AF . (1998): Excess corticotropin-releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. J Clin Invest101: 1439–1447 CASPubMedPubMed Central Google Scholar
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Okret S, Gustafsson J-A, Van der Saag PT . (1995): Negative crosstalk between RelA and the glucocorticoid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol9: 401–412 CASPubMed Google Scholar
Calvo N, Martijena ID, Molina VA, Volosin M . (1998): Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res800: 227–235 CASPubMed Google Scholar
Carroll J . (1982): Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychiatry15: 19–24 CAS Google Scholar
Chalmers DT, Lovenberg TW, De Souza EB . (1995): Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci15: 6340–6350 CASPubMedPubMed Central Google Scholar
Chen G, Kolbeck R, Barde Y-A, Bonhoeffer T, Kossel A . (1999): Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation. J Neurosci19: 7983–7990 CASPubMedPubMed Central Google Scholar
Chrousos GP, Renquist D, Brandon D, Eil C, Pugeat M, Vigersky R, Cutler GB Jr, Loriaux DL, Lipsett MB . (1982): Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci USA79: 2036–2040 CASPubMedPubMed Central Google Scholar
Cole TJ . (1996): Steroid receptor knockouts. Curr Opin Endocrinol Diabet3: 363–368 CAS Google Scholar
Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, Nemeroff CB . (1996): Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult non-human primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA93: 1619–1623 CASPubMedPubMed Central Google Scholar
Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP . (2000): Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genet24: 403–409 CASPubMed Google Scholar
de Bellis MD, Gold PW, Geracioti TD Jr, Listwak SJ, Kling MA . (1993): Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry150: 656–657 CASPubMed Google Scholar
de Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M . (1998): Brain corticosteroid receptor balance in health and disease. Endocrinol Rev19: 269–301 CAS Google Scholar
de Kloet ER, Oitzl MS, Joëls M . (1999): Stress and cognition: Are corticosteroids good or bad guys? Trends Neurosci22: 422–426 CASPubMed Google Scholar
de Quervain DJ-F, Roozendaal B, McGaugh JL . (1998): Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature394: 787–790 CASPubMed Google Scholar
Deguchi M, Yoshiaki I, Matsukawa S, Yamaguchi A, Nakagawara G . (1998): Useful of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress. Surgery123: 440–449 CASPubMed Google Scholar
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR . (1990): Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry47: 411–418 CASPubMed Google Scholar
Delgado PL, Price LH, Heninger GR, Charney DS . (1992): Neurochemistry of affective disorders. In Paykel ES (ed), Handbook of Affective Disorders. New York, NY, Churchill Livingstone, pp 219–253 Google Scholar
Detera-Wadleigh SD, Berrettini WH, Goldin LR, Martinez M, Hsieh WT, Hoehe MR, Encio IJ, Coffman D, Rollins DY, Muniec D . (1992): A systematic search for a bipolar predisposing locus on chromosome 5. Neuropsychopharmacology6: 219–229 CASPubMed Google Scholar
Dijkstra I, Tilders FJH, Aguilera G, Kiss A, Rabandan-Diehl C, Barden N, Karanth S, Holsboer F, Reul JMHM . (1998): Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. J Neurosci18: 3909–3918 CASPubMedPubMed Central Google Scholar
Dodt C, Kern W, Fehm HL, Born J . (1993): Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology58: 570–574 CASPubMed Google Scholar
Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M, Schmidt TJ . (1993): Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J12: 145–156 CASPubMedPubMed Central Google Scholar
Drouin J, Maira M, Philips A . (1998): Novel mechanism of action for Nur77 and antagonism by glucocorticoids: A convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription. J Steroid Biochem Mol Biol65: 59–63 CASPubMed Google Scholar
Duman RS, Heninger GR, Nestler EJ . (1997): A molecular and cellular theory of depression. Arch Gen Psychiatry54: 597–606 CASPubMed Google Scholar
Eiring A, Sulser F . (1997): An increased synaptic availability of norepinephrine is not essential for antidepressant induced increases in hippocampal GR mRNA. J Neural Transm104: 1255–1258 CASPubMed Google Scholar
Erkut ZA, Pool C, Swaab DF . (1998): Glucocorticoids suppress corticotropin-releasing hormone and vasopessin expression in human hypothalamic neurons. J Clin Endocrinol Metab83: 2066–2073 CASPubMed Google Scholar
Flood JF, Morley JE, Roberts E . (1995): Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures; the amygdala is by far the most sensitive. Proc Natl Acad Sci USA92: 10806–10810 CASPubMedPubMed Central Google Scholar
Freedman LP . (1999): Increasing the complexity of coactivation in nuclear receptor signaling. Cell97: 5–8 CASPubMed Google Scholar
Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GB Jr, Chrousos GP . (1986): Responses to corticotropin-releasing hormone in the hypoercortisolism of depression and Cushing's disease. N Engl J Med314: 1329–1335 CASPubMed Google Scholar
Gould E, McEwen BS, Tanapat P, Galea LAM, Fuchs E . (1997): Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci17: 2492–2498 CASPubMedPubMed Central Google Scholar
Gray TS, Bingaman EW . (1996): The amygdala: Corticotropin-releasing factor, steroids, and stress. Critical Rev Neurobiol10: 155–168 CAS Google Scholar
Greden F, Gardner R, King D, Grunhaus L, Carroll J, Kronfol Z . (1983): Dexamethasone suppression test in antidepressant treatment of melancholia. Arch Gen Psychiatry40: 493–500 CASPubMed Google Scholar
Hassan AHS, von Rosenstiel P, Patchev VK, Holsboer F, Almeida OFX . (1996): Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol140: 43–52 CASPubMed Google Scholar
Hassan AHS, Patchev VK, von Rosenstiel P, Holsboer F, Almeida OFX . (1999): Plasticity of hippocampal corticosteroid receptors during aging in the rat. FASEB J13: 115–122 CASPubMed Google Scholar
Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE . (1999): Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology145: 303–308 CASPubMed Google Scholar
Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato ACB . (1994): A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J13: 4087–4095 CASPubMedPubMed Central Google Scholar
Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB . (2000): Increased pituitary-adrenal and autonomic responses to stress in adult women after sexual and physical abuse in childhood. JAMA, In press.
Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT . (1997): Corticotropin-releasing factor CRF1, but not CRF2 receptors mediate anxiogenic-like behavior. Regul Peptides71: 15–21 CAS Google Scholar
Heuser I, Yassouridis A, Holsboer F . (1994): The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatric Res28: 341–356 CAS Google Scholar
Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F . (1996): Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal comparison subjects. Am J Psychiatry153: 93–99 CASPubMed Google Scholar
Holsboer F . (1999): The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatric Res33: 181–214 CAS Google Scholar
Holsboer F, Barden N . (1996): Antidepressants and HPA regulation. Endocrinol Rev17: 187–203 CAS Google Scholar
Holsboer F, Liebl R, Hofschuster E . (1982): Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J Affect Disord4: 93–101 CASPubMed Google Scholar
Holsboer F, Gerken A, Von Bardeleben U, Grimm W, Beyer H, Müller OA, Stalla GK . (1986): Human corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Biol Psychiatry21: 601–611 CASPubMed Google Scholar
Holsboer F, Von Bardeleben U, Wiedemann K, Müller OA, Stalla GK . (1987): Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression—implications for pathophysiology of DST nonsuppression. Biol Psychiatry22: 228–234 CASPubMed Google Scholar
Holsboer F, Spengler D, Heuser I . (1992): The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res93: 385–417 CASPubMed Google Scholar
Holsboer F, Lauer CJ, Schreiber W, Krieg J-C . (1995): Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology62: 340–347 CASPubMed Google Scholar
Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V . (1994): Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment—neurobiological and psychometric assessment of course. J Psychiatric Res28: 381–399 CAS Google Scholar
Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y, Duman RS, Nestler EJ . (1994): Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron13: 1235–1244 CASPubMed Google Scholar
Huizenga NATM, Koper JW, de Lange P, Pols HAP, de Jong FH, Stolk RP, Grobbee DE, Lamberts SWJ . (1998): Interperson variability, but intraperson reproducibililty of baseline cortisol concentrations and its relation to the feedback sensitivity of the hypothalamo-pituitary-adrenal axis to low dose dexamethasone. J Clin Endocrinol Metab83: 47–54 CASPubMed Google Scholar
Joëls M, de Kloet ER . (1992): Control of neuronal excitability by corticosteroid hormones. Trends Neurosci15: 25–30 PubMed Google Scholar
Kafitz KW, Rose CR, Thoenen H, Konnerth A . (1999): Neurotrophin-evoked rapid excitation through TrkB receptors. Nature401: 918–921 CASPubMed Google Scholar
Kanelakis KC, Morishima Y, Dittmar KD, Galigniana MD, Takayama S, Reed JC, Pratt WB . (1999): Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J Biol Chem274: 34134–34140 CASPubMed Google Scholar
Kang KI, Meng X, Devin-Leclerc J, Bouhouche I, Chadli A, Cadepond F, Baulieu E-E, Catelli M-G . (1999): The molecular chaperone hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc Natl Acad Sci USA96: 1439–1444 CASPubMedPubMed Central Google Scholar
Karanth S, Linthorst ACE, Stalla GK, Barden N, Holsboer F, Reul JMHM . (1997): Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology138: 3476–3485 CASPubMed Google Scholar
Karolyi IJ, Burrows HL, Ramesh TM, Nakajima M, Lesh JS, Seong E, Camper SA, Seasholtz AF . (1999): Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci USA96: 11595–11600 CASPubMedPubMed Central Google Scholar
Kendler KS, Karkowski LM, Prescott CA . (1999): Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry156: 837–841 CASPubMed Google Scholar
Kerr DS, Campell LW, Applegate MD, Brodish A, Landfield PW . (1991): Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci11: 1316–1324 CASPubMedPubMed Central Google Scholar
Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J . (2000): Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genet24: 415–419 CASPubMed Google Scholar
Koper JW, Stolk RP, de Lange P, Huizenga NATM, Molijn G-J, Pols HAP, Grobbee DE, Karl M, de Jong FH, Brinkmann AO, Lamberts SWJ . (1997): Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Human Genet99: 663–668 CAS Google Scholar
Korte M, Carroll P, Wolff E, Brem G, Thoenen H, Bonhoeffer T . (1995): Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA92: 8856–8860 CASPubMedPubMed Central Google Scholar
Korte M, Griesbeck O, Gravel C, Carroll P, Staiger V, Thoenen H, Bonhoeffer T . (1996): Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci USA93: 12547–12552 CASPubMedPubMed Central Google Scholar
Lackner C, Daufeldt S, Wildt L, Alléra A . (1998): Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane. Kinetics of corticosterone uptake by isolated membrane vesicles. III. Specificity and stereospecificity. J Steroid Biochem Mol Biol64: 69–82 CASPubMed Google Scholar
Ladd CO, Owens MJ, Nemeroff CB . (1996): Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology137: 1212–1218 CASPubMed Google Scholar
Lamberts SWJ, Koper JW, Biemond P, den Holder FH, de Jong FH . (1992): Cortisol receptor resistance: The variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab74: 313–321 CASPubMed Google Scholar
Lamberts SWJ, Huizenga ATM, de Lange P, de Jong FH, Koper JW . (1996): Clinical aspects of glucocorticoid sensitivity. Steroids61: 157–160 CASPubMed Google Scholar
Landfield PW, Baskin RK, Pitler TA . (1981): Brain aging correlates: Retardation by hormonal-pharmacological treatments. Science214: 581–584 CASPubMed Google Scholar
Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai M-J, O'Malley BW . (1999): A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell97: 17–274 CASPubMed Google Scholar
Lauer CJ, Schreiber W, Modell S, Holsboer F, Krieg J-C . (1998): The Munich vulnerability study of affective disorders. J Psychiatric Res32: 393–401 CAS Google Scholar
Legradi G, Holzer D, Kapcala LP, Lechan RM . (1997): Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology66: 86–97 CASPubMed Google Scholar
Leverenz JB, Wilkinson CW, Wamble M, Corbin S, Grabber JE, Raskind MA, Peskind ER . (1999): Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J Neurosci19: 2356–2361 CASPubMedPubMed Central Google Scholar
Levine S, Mullins RF . (1966): Hormonal influences on brain organization in infant rats. Science152: 1585–1592 CASPubMed Google Scholar
Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A . (1995): Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Peptides59: 229–239 CAS Google Scholar
Liebsch G, Landgraf R, Engelmann M, Lörscher P, Holsboer F . (1999): Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligodeoxynucleotides into the rat brain. J Psychiatric Res33: 153–163 CAS Google Scholar
Linthorst ACE, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JMHM . (1997): Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci17: 4448–4460 CASPubMedPubMed Central Google Scholar
Linthorst ACE, Karanth S, Barden N, Holsboer F, Reul JMHM . (1999): Impaired glucocorticoid receptor function evolves in aberrant physiological responses to bacterial endotoxin. Eur J Neurosci11: 178–186 CASPubMed Google Scholar
Linthorst ACE, Flachskamm C, Barden N, Holsboer F, Reul JMHM . (2000): Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: An in vitro microdialysis study in transgenic mice. Eur J Neurosci12: 283–291 CASPubMed Google Scholar
Liu J, DeFranco DB . (1999): Chromatin recycling of glucocorticoid receptors: Implications for multiple roles of heat shock protein 90. Mol Endocrinol13: 355–365 CASPubMed Google Scholar
Lôo H, Saiz-Ruiz J, Costa e Silva JA, Ansseau M, Herrington R, Vaz-Serra A, Dilling H, de Risio S . (1999): Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. J Affect Disord56: 109–118 PubMed Google Scholar
Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney MJ . (1998): Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci1: 69–73 CASPubMed Google Scholar
Magariños AM, McEwen BS, Flügge G, Fuchs E . (1996): Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci16: 3534–3540 PubMedPubMed Central Google Scholar
Magariños AM, Verdugo JM, McEwen BS . (1997): Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA94: 14002–14008 PubMedPubMed Central Google Scholar
Malkoski SM, Handanos CM, Dron RI . (1997): Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol Cell Endocrinol127: 189–199 CASPubMed Google Scholar
Malkoski SP, Dorin RI . (1999): Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol13: 1629–1644 CASPubMed Google Scholar
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM . (1995): The nuclear receptor superfamily: The second decade. Cell83: 835–839 CASPubMedPubMed Central Google Scholar
McEwen BS, Angulo J, Cameron H, Chao HM, Daniels D, Gannon MN, Gould E, Mendelson S, Sakai R, Spencer R, Woolley C . (1992): Paradoxical effects of adrenal steroids on the brain: Protection versus degeneration. Biol Psychiatry31: 177–199 CASPubMed Google Scholar
Meijer OC, Cole TJ, Schmid W, Schütz G, Joëls M, De Kloet ER . (1997): Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor. Mol Brain Res46: 290–296 CASPubMed Google Scholar
Meijer OC, de Lange ECM, Breimer DD, de Boer AG, Workel JO, De Kloet ER . (1998): Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1AP-glycoprotein knockout mice. Endocrinology139: 1789–1793 CASPubMed Google Scholar
Modell S, Yassouridis A, Huber J, Holsboer F . (1997): Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology65: 216–222 CASPubMed Google Scholar
Modell S, Lauer CJ, Schreiber W, Huber J, Krieg J-C, Holsboer F . (1998): Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology18: 253–262 CASPubMed Google Scholar
Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F . (1995): Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol7: 841–845 CASPubMed Google Scholar
Morissette J, Villeneuve A, Lordeleau L, Rochette D, Laberge C, Gagné B, Laprise C, Bouchard G, Plante M, Gobeil L, Shink E, Weissenbach J, Barden N . (1999): Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23–q24. Am J Med Genet88: 567–587 CASPubMed Google Scholar
Müller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJG, Holsboer F, Swaab DE . (1998): The human hippocampus in major depression or following administration of glucocorticoids: No evidence for major structural alterations. Soc Neurosci Abstr24: 990 Google Scholar
Murphy BEP . (1991): Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol39: 239–244 CASPubMed Google Scholar
Murphy BEP, Filipini D, Ghadirian AM . (1993): Possible use of glucocorticoid receptor antagonists in the treatment of major depression: Preliminary results using RU 486. J Psychiatry Neurosci18: 209–213 CASPubMedPubMed Central Google Scholar
Murphy EP, Conneely OM . (1997): Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinology11: 39–47 CAS Google Scholar
Nelson MD, Saykin AJ, Flashman LA, Riordan HJ . (1998): Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. A meta-analytic study. Arch Gen Psychiatry55: 433–440 CASPubMed Google Scholar
Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts DC, Loosen PT, Vale W . (1984): Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science226: 1342–1344 CASPubMed Google Scholar
Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M . (1988): Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry45: 377–379 Google Scholar
Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL . (1999): Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry56: 527–533 CASPubMed Google Scholar
Nollen EAA, Brunsting JF, Song J, Kampinga HH, Morimoto RI . (2000): Bag1 functions in vivo as a negative regulator of hsp70 chaperone activity. Mol Cell Biol20: 1083–1088 CASPubMedPubMed Central Google Scholar
O'Dwyer AM, Lightman SL, Marks M, Checkley SA . (1995): Treatment of major depression with metyrapone and hydrocortisone. J Affect Disord33: 123–128 CASPubMed Google Scholar
Oitzl MS, Fluttert M, De Kloet ER . (1994): The effect of corticosterone on reacitivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci6: 1072–1079 CASPubMed Google Scholar
Orchinik M, Murrey TF, Moore FL . (1991): A corticosteroid receptor in neuronal membranes. Science252: 1848–1851 CASPubMed Google Scholar
Owens MJ, Nemeroff CB . (1991): Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev43: 425–473 CASPubMed Google Scholar
Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH . (1997): Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol52: 571–581 CASPubMed Google Scholar
Patchev VK, Shoaib M, Holsboer F, Almeida OFX . (1994): The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience62: 265–271 CASPubMed Google Scholar
Patchev VK, Hassan AHS, Holsboer F, Almeida OFX . (1996): The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology15: 533–540 CASPubMed Google Scholar
Patchev VK, Montkowski A, Rouskova D, Koranyi L, Holsboer F, Almeida OFX . (1997): Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest99: 962–966 CASPubMedPubMed Central Google Scholar
Pepin MC, Pothier F, Barden N . (1992): Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature355: 725–728 CASPubMed Google Scholar
Pfahl M . (1993): Nuclear receptor/AP-1 interaction. Endocrinol Rev14: 651–658 CAS Google Scholar
Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P, Drouin J . (1997): Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol17: 5952–5959 CASPubMedPubMed Central Google Scholar
Plotsky P, Meaney M . (1993): Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF-content and stress-induced release in adult rats. Mol Brain Res18: 195–200 CASPubMed Google Scholar
Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW . (1991): Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature349: 423–426 CASPubMed Google Scholar
Pratt WB, Dittmar KD . (1998): Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor-hsp90 heterocomplex assembly. TEM9: 244–252 CASPubMed Google Scholar
Purba JS, Hoogendijk WJG, Hofman MA, Swaab DF . (1996): Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry53: 137–143 CASPubMed Google Scholar
Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FHJ, Swaab DF . (1994): Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology60: 433–436 Google Scholar
Radulovic J, Rühmann A, Liepold T, Spiess J . (1999): Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2. J Neurosci19: 5016–5025 CASPubMedPubMed Central Google Scholar
Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA . (1999): Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry45: 1085–1098 CASPubMed Google Scholar
Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schütz G . (1998): DNA binding of the glucocorticoid receptor is not essential for survival. Cell93: 531–541 CASPubMed Google Scholar
Reynolds PD, Ruan Y, Smith DF, Scammell JG . (1999): Glucocorticoid resistance in the squirrel monkeys is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab84: 663–669 CASPubMed Google Scholar
Reul JMHM, Stec I, Söder M, Holsboer F . (1993): Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology133: 312–320 CASPubMed Google Scholar
Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F . (1994): Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology60: 509–519 CASPubMed Google Scholar
Reul JMHM, Probst JC, Skutella T, Hirschmann M, Stec IS, Montkowski A, Landgraf R, Holsboer F . (1997): Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. Neuroendocrinology65: 189–199 CASPubMed Google Scholar
Rochford J, Beaulieu S, Rousse I, Glowa J, Barden N . (1997): Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: Effects of diazepam and FG-7142. Psychopharmacology132: 145–152 CASPubMed Google Scholar
Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R . (1998): Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry155: 910–913 CASPubMed Google Scholar
Roozendaal B, Nguyen BT, Power AE, McGaugh JL . (1999): Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation. Proc Natl Acad Sci USA96: 11642–11647 CASPubMedPubMed Central Google Scholar
Rossby SP, Nalepa I, Huang M, Burt A, Perrin C, Schmidt DE, Sulser F . (1995): Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res687: 79–82 CASPubMed Google Scholar
Rossby SP, Manier DH, Liang S, Nalepa I, Sulser F . (1999): Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors. Intl J Neuropsychopharmacol2: 1–8 CAS Google Scholar
Rousse I, Beaulieu S, Rowe W, Meaney MJ, Barden N, Rochford J . (1997): Spatial memory in transgenic mice with impaired glucocorticoid receptor function. NeuroReport8: 841–845 CASPubMed Google Scholar
Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett ALN . (1987): Neuroendocrine aspects of primary endogenous depression. Arch Gen Psychiatry44: 328–336 CASPubMed Google Scholar
Rupprecht R, Holsboer F . (1999): Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci22: 410–416 CASPubMed Google Scholar
Rupprecht R, Reul JMHM, Trapp T, van Steensel B, Wetzel C, Zieglgänsberger W, Damm K, Holsboer F . (1993): Progesterone receptor mediated effects of neuroactive steroids. Neuron11: 523–530 CASPubMed Google Scholar
Rybakowski JK, Twardowska K . (1999): The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatric Res33: 363–370 CAS Google Scholar
Sánchez MM, Young LJ, Plotsky PM, Insel TR . (1999): Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol408: 365–377 PubMed Google Scholar
Sánchez MM, Young LJ, Plotsky PM, Insel TR . (2000): Distribution of corticosteroid receptors in the rhesus brain: Relative absence of glucocorticoid receptors in the hippocampal formation. J Neuroscience20: 4657–4668 Google Scholar
Sapolsky RM . (1992): Stress, the Aging Brain and the Mechanism of Neuron Death. London, MIT Press Google Scholar
Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO . (1985): A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatric Res19: 57–64 CAS Google Scholar
Schinkel AH, Wagenaar E, Van Deemter L, Mol CAAM, Borst P . (1995): Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest96: 1698–1705 CASPubMedPubMed Central Google Scholar
Schneikert J, Hübner S, Martin E, Cato ACB . (1999): A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J Cell Biol146: 929–940 CASPubMedPubMed Central Google Scholar
Schulkin J, Gold PW, McEwen BS . (1998): Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology23: 219–243 CASPubMed Google Scholar
Schwaninger M, Schoel C, Blume R, Rossig L, Knepel W . (1995): Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol Pharmacol47: 1112–1118 CASPubMed Google Scholar
Seasholtz AF, Thompson RC, Douglass JO . (1988): Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol2: 1311–1319 CASPubMed Google Scholar
Seckl JR . (1997): 11β-Hydroxysteroid dehydrogenase in the brain: A neural regulator of glucocorticoid action? Front Neuroendocrinol18: 49–99 CASPubMed Google Scholar
Seckl JR, Fink G . (1992): Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology55: 621–626 CASPubMed Google Scholar
Seckl JR, Dickson KL, Yates C, Fink G . (1991): Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res561: 332–337 CASPubMed Google Scholar
Sheline YI, Wang PW, Gado MH, Hsernansky JG, Vannier MW . (1996): Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA93: 3908–3913 CASPubMedPubMed Central Google Scholar
Sheline YI, Gado M, Price JL . (1998): Amygdala core nuclei volumes are decreased in recurrent major depression. NeuroReport9: 2023–2028 CASPubMed Google Scholar
Sheline YI, Sanghavi M, Mintun MA, Gado MH . (1999): Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci19: 5034–5043 CASPubMedPubMed Central Google Scholar
Shelton RC, Manier DH, Peterson CS, Truitt CE, Sulser F . (1999): Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers. Intl J Neuropsychopharmacol2: 187–192 CAS Google Scholar
Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai M-J, O'Malley BW . (1997): Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Rec Progr Hormone Res52: 141–163 CAS Google Scholar
Sillaber I, Montkowski A, Landgraf R, Barden N, Holsboer F, Spanagel R . (1998): Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: Influence of long-term treatment with the antidepressant moclobemide. Neuroscience85: 415–425 CASPubMed Google Scholar
Siuciak JA, Lewis D, Wiegand SJ, Lindsay RM . (1996): Antidepressant-like effect of brain-derived neurotrophic factor. Pharmacol Biochem Behav56: 131–137 Google Scholar
Smith GW, Aubry J-M, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee K-F . (1998): Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron20: 1093–1103 CASPubMed Google Scholar
Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A . (1996): Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression4: 1–13 CASPubMed Google Scholar
Spanagel R, Stöhr T, Barden N, Holsboer F . (1996): Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol8: 93–97 CASPubMed Google Scholar
Spencer RL, Kim PJ, Kalman BA, Cole MA . (1998): Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology139: 2718–2726 CASPubMed Google Scholar
Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai M-J, O'Malley BW . (1997): Steroid receptor coactivator-1 is a histone acetyltransferase. Nature389: 194–198 CASPubMed Google Scholar
Spengler D, Rupprecht R, Phi Van L, Holsboer F . (1992): Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol6: 1931–1941 CASPubMed Google Scholar
Stalla GK, Stalla J, von Werder K . (1989): Nitroimidazole derivates inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme. Endocrinology155: 699–706 Google Scholar
Stec I, Barden N, Reul JMHM, Holsboer F . (1994): Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatric Res28: 1–5 CAS Google Scholar
Steckler T, Weis C, Sauvage M, Mederer A, Holsboer F . (1999): Disrupted allocentric but preserved egocentric spatial learning in transgenic mice with impaired glucocorticoid receptor function. Behav Brain Res100: 77–89 CASPubMed Google Scholar
Steckler T, Sauvage M, Holsboer F . (2000a): Glucocorticoid receptor impairment enhances impulsive responding in transgenic mice performing on a simultaneous visual discrimination task. Eur J Neuroscience, In press.
Steckler T, Rammes G, Sauvage M, van Gaalen MM, Weis C, Zieglgänsberger W, Holsboer F . (2000b): Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. J Psychiatric Res, In press.
Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW . (1994): Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. J Neurosci14: 2579–2584 CASPubMedPubMed Central Google Scholar
Stoecklin E, Wissler M, Gouilleux F, Groner B . (1996): Functional interactions between Stat5 and the glucocorticoid receptor. Nature383: 726–728 CAS Google Scholar
Stoecklin E, Wissler M, Moriggl R, Groner B . (1997): Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional co-operation in the regulation of gene transcription. Mol Cell Biol17: 6708–6716 CASPubMedPubMed Central Google Scholar
Ströhle A, Poettig M, Barden N, Holsboer F, Montkowski A . (1998): Age- and stimulus-dependent changes in anxiety-related behaviour of transgenic mice with GR dysfunction. NeuroReport9: 2099–2102 PubMed Google Scholar
Ströhle A, Pasini A, Romeo E, Hermann B, Spalletta G, di Michele F, Holsboer F, Rupprecht R . (2000): Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression. J Psychiatric Res34: 183–186 Google Scholar
Swanson LW, Simmons DM . (1989): Differential steroid hormones and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J Comp Neurol285: 413–435 CASPubMed Google Scholar
Thakore JH, Dinan TG . (1995): Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry37: 364–368 CASPubMed Google Scholar
Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W . (1998): Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet19: 162–166 CASPubMed Google Scholar
Trapp T, Rupprecht R, Castrèn M, Reul JMHM, Holsboer F . (1994): Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron13: 1457–1462 CASPubMed Google Scholar
Trapp T, Holsboer F . (1996a): Heterodimerization between mineralocorticoid and glucocorticoid receptor increases the functional diversity of corticosteroid action. Trends in Pharmacol Sci17: 145–149 CAS Google Scholar
Trapp T, Holsboer F . (1996b): Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activity. J Biol Chem271: 9879–9882 CASPubMed Google Scholar
Tronche R, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G . (1999): Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genet23: 99–103 CASPubMed Google Scholar
Uhr M, Steckler T, Yassouridis A, Holsboer F . (2000): Penetration of amitriptyline, but not fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology22: 380–387 CASPubMed Google Scholar
Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A . (1998): Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA95: 3239–3244 CASPubMedPubMed Central Google Scholar
Vale W, Spiess J, Rivier C, Rivier J . (1981): Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science213: 1394–1397 CASPubMed Google Scholar
van der Burg B, Liden J, Okret S, Delaunay F, Wissink S, van der Saag PT, Gustafsson J-A . (1997): Nuclear factor-κB repression in antiinflammation and immunosuppression by glucocorticoids. Trends Endocrinol Metab8: 152–157 CASPubMed Google Scholar
van Haarst AD, Welberg LAM, Sutanto W, Oitzl MS, De Kloet ER . (1996a): 11β-Hydroxysteroid dehydroxygenase activity in the hippocampus: Implications for in vivo corticosterone receptor binding and cell nuclear retention. J Neuroendocrinol8: 595–600 CASPubMed Google Scholar
van Haarst AD, Oitzl MS, Workel JO, De Kloet ER . (1996b): Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology137: 4935–4943 CASPubMed Google Scholar
von Bardeleben U, Holsboer F . (1989): Cortisol response to a combined dexamethasone-hCRH challenge in patients with depression. J Neuroendocrinol1: 485–488 CAS Google Scholar
von Bardeleben U, Holsboer F . (1991): Effect of age upon the cortisol response to human CRH in depressed patients pretreated with dexamethasone. Biol Psychiatry29: 1042–1050 CASPubMed Google Scholar
von Bardeleben U, Holsboer F, Stalla GK, Müller OA . (1985): Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci37: 1613–1619 CASPubMed Google Scholar
Watanabe Y, Gould E, McEwen BS . (1992): Stress induces atrophy of spatial dendrites of hippocampal CA3 pyramidal neurons. Brain Res588: 341–345 CASPubMed Google Scholar
Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, Berridge CW, Majzoub JA . (1999): Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA96: 8283–8288 CASPubMedPubMed Central Google Scholar
Wissink S, van Heerde EC, van der Burg B, van der Saag PT . (1998): A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol12: 355–363 CASPubMed Google Scholar
Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J . (1999): Antiglucocorticoid treatment of depression: Double-blind ketoconazole. Biol Psychiatry45: 1070–1074 CASPubMed Google Scholar
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H . (1998): The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab83: 3339–3345 CASPubMed Google Scholar
Zeiner M, Niyaz Y, Gehring U . (1999): The hsp70-associating protein Hap46 binds to DNA and stimulates transcription. Proc Natl Acad Sci USA96: 10194–10199 CASPubMedPubMed Central Google Scholar
Zobel AW, Yassouridis A, Frieboes R-M, Holsboer F . (1999): Cortisol response to the combined dexamethasone-CRH test predicts medium-term outcome in patients with remitted depression. Am J Psychiatry156: 949–951 CASPubMed Google Scholar
Zobel AW, Nickel T, Künzel HE, Ackl N, Sonntag A, Ising M, Holsboer F . (2000): Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated. J Psychiatric Res, 34: 171–181 CAS Google Scholar